← All stocks

LivaNova PLC

LIVN Net selling

CIK 0001639691 #1466 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$591.84K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$591.84K

3 of 3 sales

Net

−$591.84K

−$591.84K against sales at will

By person

17 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bianchi Francesco

Director

—

$404.57K (2)

−$404.57K

4,434

0.0080%

$345.89K

−49.5%

Story Brooke

Director

—

$187.27K (1)

−$187.27K

7,488

0.0136%

$584.13K

+115.4%

Shvartsburg Alex

Chief Financial Officer

—

44,647

0.0810%

$3.48M

+138.4%

KOZY WILLIAM A

Director

—

37,566

0.0682%

$2.93M

+36.8%

Bolton Stephanie

President, Global Epilepsy

—

22,189

0.0403%

$1.73M

+132.1%

Enxing Seng Stacy

Director

—

15,307

0.0278%

$1.19M

+75.0%

Makatsaria Vladimir

Chief Executive Officer

—

14,167

0.0257%

$1.11M

—

SCHERMERHORN TODD C

Director

—

12,619

0.0229%

$984.40K

+108.3%

O'Kane Sharon

Director

—

11,304

0.0205%

$881.82K

+19.1%

Poletti Franco

President, Cardiopulmonary

—

10,755

0.0195%

$838.99K

+61.3%

WILVER PETER M

Director

—

10,294

0.0187%

$803.03K

+175.8%

Barry James Christopher

Director

—

7,918

0.0144%

$617.68K

—

Hutchinson Michael Damon

SVP, CLO and Company Secretary

—

6,798

0.0123%

$530.31K

+197.4%

Tezel Ahmet

Chief Innovation Officer

—

6,090

0.0111%

$475.08K

—

PODLOGAR SUSAN M

Director

—

5,642

0.0102%

$440.13K

—

Kozmina Natalia

Chief Human Resources Officer

—

5,015

0.0091%

$391.22K

—

Zurbay Donald

Director

—

2,252

0.0041%

$175.68K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Bianchi Francesco

10 Sep 2026

Director

Sell

3,500

$78.01

$273.03K

Story Brooke

4 Sep 2026

Director

Sell

2,300

$81.42

$187.27K

Bianchi Francesco

31 Aug 2026

Director

Sell

1,650

$79.72

$131.54K

What was left out

Form 4 filings counted 4

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 3

Transactions with no price 0

Shares from compensation/vesting 0

History held since 8 Sep 2016